BR112012005517A2 - use of guaifenesin to inhibit mucin secretion - Google Patents

use of guaifenesin to inhibit mucin secretion

Info

Publication number
BR112012005517A2
BR112012005517A2 BR112012005517A BR112012005517A BR112012005517A2 BR 112012005517 A2 BR112012005517 A2 BR 112012005517A2 BR 112012005517 A BR112012005517 A BR 112012005517A BR 112012005517 A BR112012005517 A BR 112012005517A BR 112012005517 A2 BR112012005517 A2 BR 112012005517A2
Authority
BR
Brazil
Prior art keywords
guaifenesin
mucin secretion
inhibit mucin
inhibit
secretion
Prior art date
Application number
BR112012005517A
Other languages
Portuguese (pt)
Inventor
Bruce K Rubin
Gail Solomon
Helmut Albrecht
Jeanclare Seagrave
K Chul Kim
Original Assignee
Reckitt Benckiser Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/558,517 external-priority patent/US20110065744A1/en
Priority claimed from GBGB1002039.4A external-priority patent/GB201002039D0/en
Application filed by Reckitt Benckiser Llc filed Critical Reckitt Benckiser Llc
Publication of BR112012005517A2 publication Critical patent/BR112012005517A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112012005517A 2009-09-12 2010-09-13 use of guaifenesin to inhibit mucin secretion BR112012005517A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/558,517 US20110065744A1 (en) 2009-09-12 2009-09-12 Method Of Inhibiting Mucin Secretion
GBGB1002039.4A GB201002039D0 (en) 2010-02-09 2010-02-09 Method of inhibiting mucin secretion
PCT/GB2010/051525 WO2011030163A1 (en) 2009-09-12 2010-09-13 Use of guaifenesin for inhibiting mucin secretion

Publications (1)

Publication Number Publication Date
BR112012005517A2 true BR112012005517A2 (en) 2016-04-19

Family

ID=42941393

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012005517A BR112012005517A2 (en) 2009-09-12 2010-09-13 use of guaifenesin to inhibit mucin secretion

Country Status (12)

Country Link
EP (1) EP2475360A1 (en)
JP (1) JP2013504554A (en)
KR (1) KR20120068889A (en)
CN (1) CN102596189A (en)
AU (1) AU2010294008B2 (en)
BR (1) BR112012005517A2 (en)
CA (1) CA2773611A1 (en)
MX (1) MX2012003042A (en)
MY (1) MY161187A (en)
RU (1) RU2012114323A (en)
WO (1) WO2011030163A1 (en)
ZA (1) ZA201201822B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150065539A1 (en) * 2012-04-06 2015-03-05 The Uab Research Foundation Methods for Increasing CFTR Activity
KR102211605B1 (en) * 2018-02-26 2021-02-04 대한민국 Methods for Screening Therapeutic Agents for Airway Conduct MucinSecretion Inhibitor Using the Frog Embryo

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA963590B (en) * 1995-05-10 1996-11-19 Adcock Ingram Ltd Pharmaceutical composition
US6846799B1 (en) * 1998-08-18 2005-01-25 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
EP1471872A2 (en) * 2002-02-04 2004-11-03 Pharmacia Corporation Treatment of colds and cough with a combination of a cyclooxygenase-2 selective inhibitor and a colds and cough active ingredient and compositions thereof
JP2007524618A (en) * 2003-06-19 2007-08-30 ジェネーラ・コーポレーション Mucin synthesis inhibitor
US20050095288A1 (en) * 2003-11-03 2005-05-05 Andrx Labs, Llc Decongestant and expectorant tablets
US20050266032A1 (en) * 2003-12-17 2005-12-01 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
US20080014261A1 (en) * 2006-07-12 2008-01-17 Giordano John A Non-narcotic biphasic release compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
US20090202633A1 (en) * 2008-01-03 2009-08-13 Siva Ramakrishna Velaga Extended release formulations of guaifenesin

Also Published As

Publication number Publication date
MY161187A (en) 2017-04-14
EP2475360A1 (en) 2012-07-18
AU2010294008A1 (en) 2012-04-05
WO2011030163A1 (en) 2011-03-17
RU2012114323A (en) 2013-10-20
KR20120068889A (en) 2012-06-27
CA2773611A1 (en) 2011-03-17
MX2012003042A (en) 2012-05-29
AU2010294008B2 (en) 2014-08-14
JP2013504554A (en) 2013-02-07
CN102596189A (en) 2012-07-18
ZA201201822B (en) 2013-05-29

Similar Documents

Publication Publication Date Title
BR112012001604A2 (en) personal care composition
BR112012031667A2 (en) composition
BR112013008985A2 (en) antitussive compositions comprising memantine
BR112012032683A2 (en) composition
BR112014006291A2 (en) composition and use of composition
FI20095529A0 (en) New use of probiotics
BRPI1008063A2 (en) Synthetic agonists of tlr9
BR112012010201A2 (en) modified release formulation of lacosamide
BR112012001486A2 (en) sparkling composition to generate temporary indications
BR112014013682A2 (en) personal care composition
FI20105639A0 (en) Preparation of microcellulose
BRPI1008253A2 (en) Metoso to treat biomass
BR112012032980A2 (en) composition
BR112012014028A2 (en) use of a composition
DK2453858T3 (en) COURSE OF ACTION
SMT201500113B (en) Processp to prepare alpha-carboxamide derivatives
IT1403611B1 (en) COMPOSITION OF POLYESTERS
BR112012005678A2 (en) personal care composition
BR112012015447A2 (en) topical composition for cutaneous application
FR2957252B1 (en) COSMETIC COMPOSITION
BRPI1007471A2 (en) personal care rinse compositions
CR20130294A (en) IN VITRO METHOD TO DETERMINE THE PRESENCE OF TYPE II PIRETROIDS
BR112012026860A2 (en) solid pharmaceutical composition to neutralize stomach acid
BR112012014239A2 (en) personal care composition
FR2961401B1 (en) ANTI-INFLAMMATORY COMPOSITION

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]